Clinical Trial: Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes

U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07729150) titled 'Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes' on July 22.

Brief Summary: This is a prospective, randomized, non-pharmacologic interventional trial evaluating the effectiveness of the Embr Wave wearable thermal device in reducing hot flash burden in men with prostate cancer receiving androgen deprivation therapy (ADT). Participants will be randomized 1:1 to immediate (12 weeks) versus delayed (after 6 weeks) use of the Embr Wave device. The study aims to determine whether the device reduces vasomotor symptoms using a number of patient-reported outcomes

Study Start Date: Oct. 01, 2026

Study...